FEAM

5E Advanced Materials is a self-described "development stage company" with zero revenue in every year on record (FY2021–FY2025) and a cumulative accumulated deficit of -$232M. It operates only a small-scale facility at Fort Cady; the commercial vision rests on an August 2025 Preliminary Feasibility Study for a 130,000 short-ton boric acid plant carrying an aggregate capital estimate of ~$435M (including 15% contingency). Against that, the company held just $3.84M of cash at FY2025 while burning -$23.6M in operating cash flow — roughly two months of runway. The gap between what it needs to build ($435M) and what it has is the entire investment case, and nothing in this data shows that financing is secured.

The balance sheet looks deceptively clean — liabilities/equity of only 0.12x and near-zero debt — but that is a symptom, not a strength: liabilities fell 90.4% and shares outstanding fell 67.4% YoY, consistent with a reverse split and debt-to-equity restructuring that recapitalized the company while stockholders' equity jumped 490%. Current assets ($4.61M) sit below current liabilities ($6.43M), so working capital is already negative. The 'improving' headline metrics (net loss narrowing to -$31.6M, EPS loss improving 85.5%) are dominated by share-count math and a $19.9M non-cash D&A swing (+285.8%), not by any operating progress — there is still no product being sold. R&D fell to $0.00, and capex was a token $124K, meaning the commercial plant is not being built; the company is defining reserves and studying, not producing.